Pharmaceuticals, technology and manufacturing are three themes that will play out well in India over the next decade, according to veteran investor Pankaj Murarka.
“The contract research manufacturing space in pharma is burgeoning,” Murarka, founder and chief investment officer at Renaissance Investment Managers, told BloombergQuint in an interview. “Global pharma companies are outsourcing their manufacturing to India to optimise their R&D expenses.”
“The same work done by scientists in the U.S. can be done in India at one-third of the cost,” he said, highlighting that every year India produces competent science professionals to undertake such work.
The second theme, according to Murarka, is the tech and internet industry. With higher smartphone penetration and increased data consumption, there’s tremendous opportunity for the internet economy, he said.
“India has the…